Artiva Biotherapeutics (ARTV) closed at $4.06 on November 10, 2026, down 3.8% from the previous close, on volume of 900,181 shares (30-day average 960,103).
Data as of November 10, 2026.
10-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
Artiva halts AlloNK after durability fell short and two Grade 5 events were disclosed
Market Chameleon (Tue, 27-Oct 4:55 AM ET)
Artiva Biotherapeutics Announces Strategic Update and Discontinues Development of AlloNK
Globe Newswire (Tue, 27-Oct 7:30 AM ET)
Globe Newswire (Fri, 2-Oct 9:05 AM ET)
Globe Newswire (Thu, 1-Oct 7:30 AM ET)
Globe Newswire (Wed, 23-Sep 7:30 AM ET)
Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
Globe Newswire (Thu, 17-Sep 8:00 AM ET)
Globe Newswire (Tue, 8-Sep 7:30 AM ET)
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
Globe Newswire (Wed, 2-Sep 8:30 AM ET)
Market Chameleon (Mon, 8-Jun 5:25 AM ET)
Market Chameleon (Fri, 17-Oct 5:53 AM ET)
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Artiva Biotherapeutics trades on the NASDAQ stock market under the symbol ARTV.
As of November 10, 2026, ARTV stock price declined to $4.06 with 900,181 million shares trading.
ARTV has a beta of 4.23, meaning it tends to be more sensitive to market movements. ARTV has a correlation of 0.20 to the broad based SPY ETF.
ARTV has a market cap of $198.49 million. This is considered a Micro Cap stock.
The top ETF exchange traded funds that ARTV belongs to (by Net Assets): VTI, IWM, VXF, VTWO, VFMO.
ARTV has underperformed the market in the last year with a price return of +10.9% while the SPY ETF gained +11.2%. ARTV has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -63.8% and -4.9%, respectively, while the SPY returned -2.7% and -2.6%, respectively.
ARTV support price is $4.02 and resistance is $4.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARTV shares will trade within this expected range on the day.
